Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia.
about
The changing epidemiology of Staphylococcus aureus?Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort studyA comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin.Diminished virulence of an alpha-toxin mutant of Staphylococcus aureus in experimental brain abscessesA comparison of clinical features and mortality among methicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus endocarditis.Staphylococcus aureus bacteriuria as a prognosticator for outcome of Staphylococcus aureus bacteremia: a case-control studyPredictors of Adverse Outcomes in Children With Staphylococcus aureus BacteremiaVancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: study protocol for a phase IIB randomized controlled trial.Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studiesEconomic impact of antimicrobial resistance.Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA bacteremiaPhevalin (aureusimine B) production by Staphylococcus aureus biofilm and impacts on human keratinocyte gene expression.Staphylococcus aureus infections and antibiotic resistance in older adults.A propensity score analysis shows that empirical treatment with linezolid does not increase the thirty-day mortality rate in patients with Gram-negative bacteremia.Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections.Predicting high vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus bloodstream infectionsMethicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit.Are all MRSA made equal?Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremiaComparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis.USA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections?Staphylococcus aureus bacteremia: compliance with standard treatment, long-term outcome and predictors of relapse.Illicit drug use and risk for USA300 methicillin-resistant Staphylococcus aureus infections with bacteremiaReference group choice and antibiotic resistance outcomes.Predictors of mortality in Staphylococcus aureus BacteremiaPersistent Staphylococcus aureus bacteremia: a prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates.Predictive Value of C-Reactive Protein (CRP) in Identifying Fatal Outcome and Deep Infections in Staphylococcus aureus BacteremiaCommunity-associated methicillin-resistant Staphylococcus aureus: a review.Rapid Diagnosis of Staphylococcal Catheter-Related Bacteraemia in Direct Blood Samples by Real-Time PCR.TLR9 mediates S. aureus killing inside osteoblasts via induction of oxidative stress.Survival Benefit of Empirical Therapy for Staphylococcus aureus Bloodstream Infections in Infants.Defining the need for new antimicrobials: clinical and economic implications of resistance in the hospitalised patient.Risk factors for nosocomial infective endocarditis in patients with methicillin-resistant Staphylococcus aureus bacteremia.Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late MortalityUnderlying disorders and their impact on the host response to infection.Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer centerOutcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremiaPharmacoeconomics of treatment with the newer anti-Gram-positive agents.Epidemiology and outcome of major postoperative infections following cardiac surgery: risk factors and impact of pathogen type.Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study
P2860
Q22305657-7B2EC6A5-B64B-4E6E-8AE8-2F28FA0C938CQ28750538-D0F933A8-7D1C-466A-8ED3-0547D3A8A2BCQ33398776-145D4E16-AF96-45A5-A53A-67E485D064E4Q33552970-8584608E-FC77-45EB-A056-B60848CB8480Q33628238-613BF0C4-2F18-43F2-8777-CE281B570AEBQ33643822-67AE99E1-51B7-4EA1-9F6F-5669FBBED0ADQ33806504-02E15C80-DF40-4FBF-9B4C-B9504452752CQ33844670-DEE3CFBD-CEDD-45C6-87CD-A32B70B03CB1Q34060175-38D2F6B1-60CE-49B4-9012-125405077D65Q34213712-385F2AFB-E8D1-4AA1-AC19-7C436B2BB4D1Q34288755-04354759-F8D2-4F74-B232-97468B75D79EQ34342521-48E11EFB-4386-448B-9422-3D92A632AFEEQ34461361-73195DCA-E784-4A2C-B585-522C22E739DFQ34597369-026FA21B-92A9-4736-BBDB-8ECFD3B95504Q34737617-54894CFC-9279-4AC9-BB60-CB8D07D3AE4EQ34756833-0FA207C3-D3D1-42E5-8197-4B9368DA6450Q34769024-6240E788-FEB3-490C-AC7F-1CE5E687E605Q34776292-82297725-320B-4B1B-BED7-450921EE7701Q34973729-30C7597F-20BA-4585-A9D5-7489B5805B78Q35030135-CF7C5D43-D0E8-49D0-8D21-70EBAB3D3616Q35056276-43B8E65E-86B1-49F7-8CCF-2DFFC5CA1ED9Q35628948-150A1D88-5DE4-4898-9601-24F09CA122A3Q35806511-27DFCFA5-74DE-416B-B50F-4D8986D39E7CQ35880537-A026B54B-8035-4573-9777-DA6D4BB18426Q35940556-34F029CC-ED84-45DF-AAFC-07B3E0BCDD23Q36008997-191CBF64-2F20-4675-8680-CEDC685E242FQ36018479-85BF5B82-3767-4AD1-B91D-6B7C09727A51Q36070903-04A5B228-9D4C-4E72-8699-095C02B79DBBQ36115773-A01DD0D8-A75D-461E-9926-C0A10A21CED0Q36156486-05C7D376-CB6F-4986-A938-3EC3ED6ED2A2Q36157258-D7A35E08-4AE9-4274-8B6A-BFBD1134C6C5Q36161246-29EB54D2-463B-43E8-ACC4-0D668470F27BQ36224748-2ED47AE9-50A2-40A7-B862-0275067753DCQ36267852-278D0BD4-2556-49BF-A7BA-7DA1B3BD1B34Q36291747-1876EC1B-13B3-4C56-8422-0DF224980F38Q36349620-4B20B552-0BC0-469F-A186-6EDB3DB1ECB1Q36422681-24739199-C63D-4527-A2FD-71A20BC85A7BQ36458452-48A52ADF-83CB-4647-A80A-D82CCB54BF62Q36503755-EAFD0DA2-26FC-4EF9-B7E4-472BB10123C1Q36565826-78563D31-B96D-4077-AE9F-18284DB8ECE2
P2860
Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Pathogenic significance of met ...... phylococcus aureus bacteremia.
@en
Pathogenic significance of met ...... phylococcus aureus bacteremia.
@nl
type
label
Pathogenic significance of met ...... phylococcus aureus bacteremia.
@en
Pathogenic significance of met ...... phylococcus aureus bacteremia.
@nl
prefLabel
Pathogenic significance of met ...... phylococcus aureus bacteremia.
@en
Pathogenic significance of met ...... phylococcus aureus bacteremia.
@nl
P2093
P2860
P356
P1476
Pathogenic significance of met ...... phylococcus aureus bacteremia.
@en
P2093
Jiménez de Anta MT
Martínez JA
Moreno-Martínez A
P2860
P304
P356
10.1086/313650
P407
P577
2000-02-01T00:00:00Z